Korea Investment Corp Crispr Therapeutics Ag Transaction History

Korea Investment Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$36.68 - $73.13 $1.66 Million - $3.31 Million	-45,300 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$40.99 - $52.56 $61,485 - $78,840	1,500 Added 3.42%	45,300 $1.86 Million
Q2 2019 Aug 12, 2019	SELL	$35.45 - $48.2 $145,345 - $197,620	-4,100 Reduced 8.56%	43,800 $2.06 Million
Q3 2018 Nov 13, 2018	SELL	$44.35 - $65.71 $350,365 - $519,108	-7,900 Reduced 14.16%	47,900 $2.12 Million
Q2 2018 Aug 13, 2018	BUY	$42.62 - $73.59 $2.38 Million - $4.11 Million	55,800 New	55,800 $0

494

64.3M

1.68M

1.95M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.88B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Korea Investment Corp with notifications on news.